Matthew Cvitanovich

Matthew Cvitanovich

Auto-generated profile, based on publicly available information

Matthew Cvitanovich

Cook Children’s Health Care System, Fort Worth, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in HIV Medicine
Verified
Journal Article
Open access
PDF file
IAIfedioranma Anikpo
Ifedioranma Anikpo
AAAfiba Manza‐A. Agovi
Afiba Manza‐A. Agovi
MCMatthew J. Cvitanovich
Matthew J. Cvitanovich
FLFrank Lonergan
Frank Lonergan
MJMarc Johnson
Marc Johnson
RORohit P. Ojha
Rohit P. Ojha
Objectives: Little is known about the external validity of the Data‐collection on Adverse Effects of Anti‐HIV Drugs (D:A:D) model for predicting cardiovascular disease (CVD) risk among people living with HIV (PLWH). We aimed to evaluate the performance of the updated D:A:D model for 5‐year CVD risk in a diverse group of PLWH engaged in HIV care.Methods: We used data from an institutional HIV registry, which includes PLWH engaged in care at a safety‐net HIV clinic. Eligible individuals had a baseline clinical encounter between 1 January 2013 and 31 December 2014, with follow‐up through to 31 December 2019. We estimated 5‐year predicted risks of CVD as a function of the prognostic index and baseline survival of the D:A:D model, which were used to assess model discrimination (C‐index), calibration and net benefit.Results: Our evaluable population comprised 1029 PLWH, of whom 30% were female, 50% were non‐Hispanic black, and median age was 45 years. The C‐index was 0.70 [95% confidence limits (CL): 0.64–0.75]. The predicted 5‐year CVD risk was 3.0% and the observed 5‐year risk was 8.9% (expected/observed ratio = 0.33, 95% CL: 0.26–0.54). The model had a greater net benefit than treating all or treating none at a risk threshold of 10%.Conclusions: The D:A:D model was miscalibrated for CVD risk among PLWH engaged in HIV care at an urban safety‐net HIV clinic, which may be related to differences in case‐mix and baseline CVD risk. Nevertheless, the HIV D:A:D model may be useful for decisions about CVD intervention for high‐risk patients.

1 April 2022 in Annals of Epidemiology
Verified
Journal Article
Closed access
TGTamala Gondwe
Tamala Gondwe
EHEmma Herbach
Emma Herbach
MCMatthew Cvitanovich
Matthew Cvitanovich
JBJoel Begay
Joel Begay
ESEndia Santee
Endia Santee
BHBertha Hidalgo
Bertha Hidalgo

7 November 2022 in Annals of Epidemiology
Verified
Journal Article
Closed access
MSMirsada Serdarevic
Mirsada Serdarevic
MCMatthew Cvitanovich
Matthew Cvitanovich
BMBrooke MacDonald
Brooke MacDonald
DDDustin DeMoss
Dustin DeMoss
JDJames D'ETienne
James D'ETienne
RORohit Ojha
Rohit Ojha

7 January 2026 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
DADevon Armstrong
Devon Armstrong
AAAfiba M.-A. Agovi
Afiba M.-A. Agovi
AGAaron W. Gehr
Aaron W. Gehr
MCMatthew Cvitanovich
Matthew Cvitanovich
EMElyse McNamara-Pittler
Elyse McNamara-Pittler
RORohit P. Ojha
Rohit P. Ojha
Post-acute care management programs are designed to optimize transitions from hospitals to skilled nursing facilities (SNFs) and reduce acute care utilizat